rs11586985

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002617.4(PEX10):​c.913-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 1,586,640 control chromosomes in the GnomAD database, including 9,839 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.088 ( 809 hom., cov: 34)
Exomes 𝑓: 0.11 ( 9030 hom. )

Consequence

PEX10
NM_002617.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00004033
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.60
Variant links:
Genes affected
PEX10 (HGNC:8851): (peroxisomal biogenesis factor 10) This gene encodes a protein involved in import of peroxisomal matrix proteins. This protein localizes to the peroxisomal membrane. Mutations in this gene result in phenotypes within the Zellweger spectrum of peroxisomal biogenesis disorders, ranging from neonatal adrenoleukodystrophy to Zellweger syndrome. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-2405838-C-T is Benign according to our data. Variant chr1-2405838-C-T is described in ClinVar as [Benign]. Clinvar id is 262791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-2405838-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PEX10NM_002617.4 linkc.913-4G>A splice_region_variant, intron_variant Intron 5 of 5 ENST00000447513.7 NP_002608.1 O60683-1A0A024R068

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PEX10ENST00000447513.7 linkc.913-4G>A splice_region_variant, intron_variant Intron 5 of 5 1 NM_002617.4 ENSP00000407922.2 O60683-1
PEX10ENST00000288774.8 linkc.973-4G>A splice_region_variant, intron_variant Intron 5 of 5 1 ENSP00000288774.3 O60683-2
PEX10ENST00000507596.5 linkc.913-10G>A intron_variant Intron 5 of 5 5 ENSP00000424291.1 D6RBB0
PEX10ENST00000650293.1 linkn.865-4G>A splice_region_variant, intron_variant Intron 5 of 7 ENSP00000497980.1 A0A3B3ITN6

Frequencies

GnomAD3 genomes
AF:
0.0878
AC:
13368
AN:
152218
Hom.:
808
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0222
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.0801
Gnomad ASJ
AF:
0.127
Gnomad EAS
AF:
0.116
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.127
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.109
GnomAD3 exomes
AF:
0.105
AC:
21178
AN:
201770
Hom.:
1171
AF XY:
0.108
AC XY:
11729
AN XY:
109072
show subpopulations
Gnomad AFR exome
AF:
0.0217
Gnomad AMR exome
AF:
0.0584
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.122
Gnomad SAS exome
AF:
0.110
Gnomad FIN exome
AF:
0.124
Gnomad NFE exome
AF:
0.122
Gnomad OTH exome
AF:
0.120
GnomAD4 exome
AF:
0.110
AC:
157972
AN:
1434304
Hom.:
9030
Cov.:
32
AF XY:
0.111
AC XY:
78588
AN XY:
711104
show subpopulations
Gnomad4 AFR exome
AF:
0.0212
Gnomad4 AMR exome
AF:
0.0617
Gnomad4 ASJ exome
AF:
0.120
Gnomad4 EAS exome
AF:
0.0914
Gnomad4 SAS exome
AF:
0.109
Gnomad4 FIN exome
AF:
0.128
Gnomad4 NFE exome
AF:
0.114
Gnomad4 OTH exome
AF:
0.112
GnomAD4 genome
AF:
0.0878
AC:
13368
AN:
152336
Hom.:
809
Cov.:
34
AF XY:
0.0888
AC XY:
6617
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.0221
Gnomad4 AMR
AF:
0.0799
Gnomad4 ASJ
AF:
0.127
Gnomad4 EAS
AF:
0.117
Gnomad4 SAS
AF:
0.101
Gnomad4 FIN
AF:
0.127
Gnomad4 NFE
AF:
0.118
Gnomad4 OTH
AF:
0.111
Alfa
AF:
0.100
Hom.:
231
Bravo
AF:
0.0813
Asia WGS
AF:
0.110
AC:
381
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 21, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Sep 26, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Peroxisome biogenesis disorder 6A (Zellweger) Benign:2
Jul 08, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Peroxisome biogenesis disorder 6B Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Peroxisome biogenesis disorder, complementation group 7 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Zellweger spectrum disorders Benign:1
Nov 21, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.20
DANN
Benign
0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000040
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11586985; hg19: chr1-2337277; COSMIC: COSV56580725; COSMIC: COSV56580725; API